Cargando…

Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis

BACKGROUND: Clinicians caring for patients with Multiple Sclerosis (MS) need improved biomarkers to aid them in disease management. OBJECTIVE: We assessed the predictive value of the candidate biomarker CXCL13 index in comparison to oligoclonal bands (OCBs) and CSF neurofilament light (NfL) concentr...

Descripción completa

Detalles Bibliográficos
Autores principales:	DiSano, Krista D, Gilli, Francesca, Pachner, Andrew R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747124/ https://www.ncbi.nlm.nih.gov/pubmed/33403120 http://dx.doi.org/10.1177/2055217320981396

Ejemplares similares

Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on “Chemokine CXCL13 in serum, CSF, and blood–CSF barrier function”
por: DiSano, Krista D., et al.
Publicado: (2021)

SeXX Matters in Multiple Sclerosis
por: Gilli, Francesca, et al.
Publicado: (2020)

Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis
por: DiSano, Krista D., et al.
Publicado: (2021)

Divergent complement system activation in two clinically distinct murine models of multiple sclerosis
por: Linzey, Michael, et al.
Publicado: (2022)

Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis
por: DiSano, Krista D., et al.
Publicado: (2019)

Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis
por: DiSano, Krista D., et al.
Publicado: (2019)

The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated Syndrome
por: Pike, Steven C., et al.
Publicado: (2023)

Clinical utility of a molecular signature in inflammatory demyelinating disease
por: Pachner, Andrew R., et al.
Publicado: (2018)

The Brave New World of Early Treatment of Multiple Sclerosis: Using the Molecular Biomarkers CXCL13 and Neurofilament Light to Optimize Immunotherapy
por: Pachner, Andrew
Publicado: (2022)

High throughput method for detecting murine brain atrophy using a clinical 3T MRI
por: Linzey, Michael, et al.
Publicado: (2023)

High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis
por: Gilli, Francesca, et al.
Publicado: (2016)

CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis
por: Phares, Timothy W., et al.
Publicado: (2016)

The Neuroimmunology of Multiple Sclerosis: Fictions and Facts
por: Pachner, Andrew R.
Publicado: (2022)

BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset
por: Puthenparampil, M., et al.
Publicado: (2017)

Intrathecal Inflammation in Progressive Multiple Sclerosis
por: Monaco, Salvatore, et al.
Publicado: (2020)

CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis
por: Lucchini, Matteo, et al.
Publicado: (2022)

Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation
por: Bielekova, Bibiana, et al.
Publicado: (2012)

CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis
por: Trolese, Maria Chiara, et al.
Publicado: (2020)

Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis
por: Londoño, Ana C., et al.
Publicado: (2018)

Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
por: Fissolo, Nicolás, et al.
Publicado: (2022)

CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2016)

Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis
por: Lin, Yen Chih, et al.
Publicado: (2015)

Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
por: Oechtering, Johanna, et al.
Publicado: (2021)

Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
por: Komori, Mika, et al.
Publicado: (2016)

Intrathecal T‐cell clonal expansions in patients with multiple sclerosis
por: de Paula Alves Sousa, Alessandra, et al.
Publicado: (2016)

CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease
por: Pierson, Sheila K., et al.
Publicado: (2022)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
por: Bar-Or, Amit, et al.
Publicado: (2014)

Correlation of increased CXCL13 with intrathecal humoral immune responses to HTLV-1 in CSF of patients with HAM/TSP
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2014)

The CXCL13/CXCR5 Immune Axis in Health and Disease—Implications for Intrathecal B Cell Activities in Neuroinflammation
por: Harrer, Christine, et al.
Publicado: (2022)

Activated GL7(+) B cells are maintained within the inflamed CNS in the absence of follicle formation during viral encephalomyelitis
por: DiSano, Krista D., et al.
Publicado: (2017)

An optimized method for enumerating CNS derived memory B cells during viral-induced inflammation
por: DiSano, Krista D., et al.
Publicado: (2017)

Serum CXCL5 as a biomarker in multiple sclerosis and neuromyelitis optica spectrum disorder
por: Karaaslan, Zerrin, et al.
Publicado: (2023)

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis
por: Vohl, Katja, et al.
Publicado: (2019)

Intrathecal kappa free light chains as markers for multiple sclerosis
por: Vecchio, D., et al.
Publicado: (2020)

Association of the retinal vasculature, intrathecal immunity, and disability in multiple sclerosis
por: Noll, Christina, et al.
Publicado: (2022)

Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis
por: Aldarwish, Walaa A., et al.
Publicado: (2023)

The fraction of varicella zoster virus-specific antibodies among all intrathecally-produced antibodies discriminates between patients with varicella zoster virus reactivation and multiple sclerosis
por: Otto, Carolin, et al.
Publicado: (2014)

Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis
por: Harris, Violaine K., et al.
Publicado: (2018)

Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis
por: Weiss, Julia Miriam, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v254dci4a2fvsifkasmc4bgcev